Form 4: Cardinal Health Director Azelby Receives Restricted Share Units
SEC Form 4 Filing
Robert Azelby, a director at Cardinal Health, acquired 1,730 common shares in the form of restricted share units on November 6, 2024.
Summary
- On November 6, 2024, Robert Azelby, a director of Cardinal Health Inc., acquired 1,730 common shares in the form of restricted share units.
- These restricted share units were granted at a price of $0 per share.
- The restricted share units will vest on November 6, 2025, unless the 2025 Annual Meeting of Shareholders occurs before that date, in which case they will vest on the meeting date.
- Following the transaction, Azelby directly owns 3,018 common shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of restricted share units to a director is a common practice and generally viewed as a positive sign, indicating confidence in the company's future.
Positives
- The acquisition of restricted share units by a director signals confidence in the company's future performance.
Future Outlook
The vesting of the restricted share units is contingent on continued service until November 6, 2025, or the date of the 2025 Annual Meeting of Shareholders if it occurs earlier.
Industry Context
Director share acquisitions are common in publicly traded companies as part of executive compensation packages, aligning management's interests with those of shareholders.
Stakeholder Impact
- The acquisition of shares by a director can positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/06/2024 | Date of transaction: Grant of 1,730 restricted share units. |
| 11/06/2025 | Vesting date of the restricted share units, unless the 2025 Annual Meeting of Shareholders is prior to this date. |
| 11/07/2024 | Date of signature by Attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.